UK on track for second vaccine doses despite supply concerns: minister
Reuters
Published Mar 28, 2021 04:21AM ET
Updated Mar 28, 2021 08:40AM ET
LONDON (Reuters) - Britain is confident second doses of COVID-19 vaccines will be administered on time without mixing jabs, culture minister Oliver Dowden said on Sunday amid concerns over a slowdown in supplies.
The government warned earlier this month that its vaccination programme would slow down in April due in part to a delay of a shipment from India's Serum Institute.
The European Union has also threatened to block vaccine shipments to countries such as the UK with higher vaccination rates.
"We have borne in mind that we have to get that second top-up in so we are confident that we will be able to deliver it," he told the BBC's Andrew Marr Show.
"We are confident that it won't require mixing of vaccines."
Dowden also said that the government still expects the Moderna (NASDAQ:MRNA) vaccine to arrive in Britain in April.
Asked about a report in The Sunday Times that the government was planning to offer 3.7 million jabs to EU member Ireland, partly to help lift lockdown measures in Northern Ireland, Dowden said Britain does not currently have extra doses.
"Should we get to the point where we have a surplus of vaccines, we'd make decisions on the allocation of that surplus," he told Sky News.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.